<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>ABOUT | Longitudinal Evaluation of Familial Frontotemporal Dementia (LEFFTDS)</title>

  <!-- Latest compiled and minified CSS -->
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">

  <!-- Optional theme -->
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap-theme.min.css" integrity="sha384-rHyoN1iRsVXV4nD0JutlnGaslCJuC7uwjduW9SVrLvRYooPp2bWYgmgJQIXwl/Sp" crossorigin="anonymous">

  <!-- Custom CSS -->
  <link rel="stylesheet" href="style.css" />

  <!-- Latest compiled and minified JS -->
  <script
  src="https://code.jquery.com/jquery-3.1.1.min.js"
  integrity="sha256-hVVnYaiADRTO2PzUGmuLJr8BLUSjGIZsDYGmIJLv2b8="
  crossorigin="anonymous"></script>

  <!-- Latest compiled and minified JavaScript -->
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script>
</head>
<body>

  <!-- navbar-->
  <header class="header">
    <div role="navigation" class="navbar navbar-default">
      <div class="container">
        <div class="navbar-header"><a href="index.html" class="navbar-brand"><img src="images/LEFFTDSlogo_150px.png" alt="LEFFTDS homepage" height="100px" ></a>
          <div class="navbar-buttons">
            <button type="button" data-toggle="collapse" data-target=".navbar-collapse" class="navbar-toggle navbar-btn">Menu<i class="fa fa-align-justify"></i></button>
          </div>
        </div>
        <div id="navigation" class="collapse navbar-collapse navbar-right">
          <ul class="nav navbar-nav">
            <li><a href="index.html">Home</a></li>
            <li class="dropdown active"><a href="#" data-toggle="dropdown" class="dropdown-toggle">About LEFFTDS <b class="caret"></b></a>
              <ul class="dropdown-menu">
                <li><a href="#ftd">Frontotemporal Dementia</a></li>
                <li><a href="#goals">Study Goals</a></li>
                <li><a href="#personnel">Study Personnel</a></li>
                <li><a href="#partners">Partners</a></li>
                <li><a href="#glossary">Glossary</a></li>
              </ul>
            </li>
            <li class="dropdown"><a href="#" data-toggle="dropdown" class="dropdown-toggle">Get Involved <b class="caret"></b></a>
              <ul class="dropdown-menu">
                <li><a href="involved.html">How to Join</a></li>
                <li><a href="involved.html#policies">Study Policies</a></li>
                <li><a href="involved.html#data">Data Requests</a></li>
              </ul>
            </li>
            <li><a href="faq.html">FAQ</a></li>
            <li><a href="news.html">News &amp; Publications</a></li>
            <li><a href="contact.html">Contact</a></li>
          </ul>
        </div>
      </div>
    </div>
  </header>

  <!-- content-->
  <section class="background-gray-lightest">
    <div class="container">
      <div class="breadcrumbs">
        <ul class="breadcrumb">
          <li><a href="index.html">Home</a></li>
          <li>About LEFFTDS</li>
        </ul>
      </div>
      <h1 class="heading">About LEFFTDS</h1>
      <p class="lead summary">Frontotemporal dementia (FTD) is the most common cause of dementia in people under age 60. The goal of the LEFFTDS study is to identify the best ways to track the progression of FTD in order to design better clinical trials. Partner sites are located across the United States and in Vancouver, Canada.</p>
    </div>
  </section>

  <section class="blog-post">
    <div class="container">
      <div class="row">
        <div class="col-lg-8">
          <div class="post-content">
            <h2 id="ftd">What is Frontotemporal Dementia?</h2>
            <p>Frontotemporal lobar degeneration (FTLD) is the umbrella term for a group of progressive, degenerative brain diseases that gradually destroy the ability to behave appropriately, empathize with others, learn, reason, make judgments, communicate, and carry out daily activities. These diseases include behavioral variant frontotemporal dementia (FTD), semantic variant primary progressive aphasia (svPPA), nonfluent/agrammatic variant primary progressive aphasia (nfvPPA), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP). There are several forms of the disease that lead to slightly different behavioral, language and/or motor symptoms. Due to the symptoms, FTLD can be mistaken for Alzheimer's disease, Parkinson's disease or a primarily psychiatric disorder like depression, manic-depression, obsessive-compulsive disease or schizophrenia. There is no treatment or cure yet that can reverse the damage, but medications and lifestyle changes can help relieve the symptoms. FTLD is not contagious.</p>
            <h3>Who gets FTLD syndromes?</h3>
            <p>People all over the world get FTLD. In people under age 60, FTLD is the most common cause of dementia and affects as many people as Alzheimer's disease in the 45&ndash;64 age group. Both men and women can develop FTLD, but it is more common in men.</p>
            <h3>What causes FTLD?</h3>
            <p>In most cases, the cause of FTLD is unknown. Approximately 40% of people with FTLD have a family history of FTD or another related dementia, while 5–10% of patients have a family history that shows an autosomal dominant inheritance pattern. This means that a child of someone with a disease has a 50% chance of inheriting the same illness-causing trait.</p>
            <h3>How is FTLD diagnosed? </h3>
            <p>People with FTLD typically first come to the doctor's office because of gradual and steady changes in behavior, language dysfunction or weakness or slowing of movement. The diagnosis of FTLD is made by reviewing the data from a neurological exam, neuropsychological testing, laboratory tests, and neuroimaging studies.</p>
            <h3>What is the treatment for FTLD? </h3>
            <p>There is no treatment or cure yet that can reverse the damage, but medications and lifestyle changes can help relieve the symptoms.</p>
            <h2 id="goals">Goals of the LEFFTDS Study</h2>
            <p>This observational study will enroll people from families affected by familial frontotemporal dementia. At least one relative must have a known mutation in the <em>MAPT, PGRN,</em> or <em>C9ORF72</em> genes. The study will include 100 mutation carriers with mild dementia or minimal symptoms but no dementia, 100 mutation carriers without symptoms, and 100 clinically normal noncarriers.</p>
            <p>Participants will undergo assessments, including different kinds of magnetic resonance imaging;  magnetic resonance spectroscopy; cerebrospinal fluid and blood sampling; and behavioral, neuropsychological, and functional tests. Investigators will measure changes in cognition during 3 years shown by these test results.</p>
            <p>A primary goal of this study is to identify the most robust and reliable methods to track disease progression in familial frontotemporal dementia so that clinical trials of disease-modifying therapies can be designed appropriately.</p>
            <h2 id="personnel">LEFFTDS Personnel</h2>
            <p>Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Vestibulum tortor quam, feugiat vitae, ultricies eget, tempor sit amet, ante. Donec eu libero sit amet quam egestas semper. Aenean ultricies mi vitae est. Mauris placerat eleifend leo. Quisque sit amet est et sapien ullamcorper pharetra. Vestibulum erat wisi, condimentum sed, commodo vitae, ornare sit amet, wisi. Aenean fermentum, elit eget tincidunt condimentum, eros ipsum rutrum orci, sagittis tempus lacus enim ac dui. Donec non enim in turpis pulvinar facilisis. Ut felis. Praesent dapibus, neque id cursus faucibus, tortor neque egestas augue, eu vulputate magna eros eu erat. Aliquam erat volutpat. Nam dui mi, tincidunt quis, accumsan porttitor, facilisis luctus, metus</p>
            <h2 id="partners">Partners</h2>
            <p>LEFFTDS study partners include:</p>
            <ul>
              <li>UCSF Memory and Aging Center</li>
              <li>Mayo Clinic Florida</li>
              <li>Harvard University</li>
              <li>Mayo Clinic Rochester</li>
              <li>Washington University</li>
              <li>Columbia University</li>
              <li>University of Pennsylvania</li>
              <li>University of British Columbia</li>
            </ul>
            <h2 id="glossary">Glossary</h2>
            <dl>
              <dt>Agnosia</dt>
              <dd>A loss of the ability to recognize objects, persons, sounds, shapes or smells without injury to the primary sensory organ or memory loss</dd>
              <dt>Agrammatism</dt>
              <dd>The presence of grammatical errors in speech, such as the omission or incorrect usage of articles (“cow jumped over moon”), prepositions (“dog walk bridge”) or verbs (“cat eated mouse”)</dd>
            </dl>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- footer-->
  <footer class="footer">
    <div class="footer__copyright">
      <div class="container">
        <div class="row">
          <div class="col-md-12">
            <p>&copy; 2016 The Regents of the University of California</p>
          </div>
        </div>
      </div>
    </div>
  </footer>

</body>
</html>
